Involvement of mitochondrial DNA sequence variations and respiratory activity in late complications following radiotherapy

Clinical Cancer Research

Volumn 15, Issue 23, 2009, Pages 7352-7360

  Alsbeih, Ghazi A ^a   Al Harbi, Najla M ^a   El Sebaie, Medhat M ^a   Al Rajhi, Nasser M ^a   Al Hadyan, Khaled S ^a   Abu Amero, Khaled K ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FIBROSIS; GENE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MALE; MITOCHONDRIAL RESPIRATION; NASOPHARYNX CARCINOMA; ND3 GENE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOSENSITIVITY;

ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; CELL NUCLEUS; DNA, MITOCHONDRIAL; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; NASOPHARYNGEAL NEOPLASMS; OXAZINES; OXYGEN CONSUMPTION; RADIATION, IONIZING; RADIOTHERAPY; REACTIVE OXYGEN SPECIES; RISK; XANTHENES;

EID: 73149120050     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0960     Document Type: Article

References (33)

1. Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003;4:529-36.
2. Peters LJ. Radiation therapy tolerance limits. For one or for all? Cancer 1996;77:2379-85.
3. Tucker SL, Geara FB, Peters LJ, Brock WA. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother Oncol 1996;38:103-13.
4. Guirado D, Ruiz de Almodovar JM. Prediction of normal tissue response and individualization of doses in radiotherapy. Phys Med Biol 2003;48:3213-23.
5. Varon R, Vissinga C, Platzer M, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998;93:467-76.
6. Rogers PB, Plowman PN, Harris SJ, Areltt CF. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol 2000;57:143-54.
7. Fernet M, Gribaa M, Salih MA, Seidahmed MZ, Hall J, Koenig M. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Mol Genet 2005;14:307-18.
8. Fernet M, Hall J. Genetic biomarkers of therapeutic radiation sensitivity. DNA Repair (Amst) 2004;3:1237-43.
9. Alsbeih G, El-Sebaie M, Al-Harbi N, Al-Buhairi M, Al-Hadyan K, Al-Rajhi N. Radiosensitivity of human fibroblasts is associated with amino acid substitution variants in susceptible genes and correlates with the number of risk alleles. Int J Radiat Oncol Biol Phys 2007;68:229-35.
10. Azria D, Ozsahin M, Kramar A, et al. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 2008;14:6284-8.
11. Suga T, Ishikawa A, Kohda M, et al. Haplotypebased analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2007;69:685-93.
12. Alsner J, Andreassen CN, Overgaard J. Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin Radiat Oncol 2008;18:126-35.
13. Rodemann HP, Peterson HP, Schwenke K, von Wangenheim KH. Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microsc 1991;5:1135-42.
14. Herskind C, Bentzen SM, Overgaard J, Overgaard M, Bamberg M, Rodemann HP. Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy. Radiother Oncol 1998;47:263-9.
15. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005;39:359-407.
16. Abu-Amero KK, Bosley TM. Detection of mitochondrial respiratory dysfunction in circulating lymphocytes using resazurin. Arch Pathol Lab Med 2005;129:1295-8.
17. Morales A, Miranda M, Sanchez-Reyes A, Biete A, Fernandez-Checa JC. Oxidative damage of mitochondrial and nuclear DNA induced by ionizing radiation in human hepatoblastoma cells. Int J Radiat Oncol Biol Phys 1998;42:191-203.
18. Al-Amro A, Al-Rajhi N, Khafaga Y, et al. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2005;62:508-13.
19. Cox DJ, Stetz J, Pajak FT. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
20. Rieder MJ, Taylor SL, Tobe VO, Nickerson DA. Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome. Nucleic Acids Res 1998;26:967-73.
21. Strom E, Sathe S, Komarov PG, et al. Small-molecule inhibitor of p53bin ding to mitochondria protects mice from gamma radiation. Nat Chem Biol 2006;2:474-9.
22. Lertrit P, Kapsa RM, Jean-Francois MJ, et al. Mitochondrial DNA polymorphism in disease: a possible contributor to respiratory dysfunction. Hum Mol Genet 1994;3:1973-81.
23. Kazuno AA, Munakata K, Nagai T, et al. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet 2006;2:e128.
24. MacCallum DE, Hupp TR, Midgley CA, et al. The p53res ponse to ionising radiation in adult and developing murine tissues. Oncogene 1996;13:2575-87.
25. Damaraju S, Murray D, Dufour J, et al. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res 2006;12:2545-54.
26. Shadel GS, Clayton DA. Mitochondrial DNA maintenance in vertebrates. Annu Rev Biochem 1997;66:409-35.
27. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003;3:193-202.
28. Chevrollier A, Guillet V, Loiseau D, et al. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol 2008;63:794-8.
29. Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene 2005;24:1455-60.
30. Trifunovic A, Hansson A, Wredenberg A, et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci U S A 2005;102:17993-8.
31. Wallace DC. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 2005;354:169-80.
32. Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, et al. A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease. Ann N Y Acad Sci 2008;1147:1-20.
33. Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet 2009;46:145-58.